๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Lung Adenocarcinoma
Clinical trial register · China

Lung Adenocarcinoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 8 Wuhan 2 Chengdu 2 Chongqing 2 Guangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai8 Wuhan2 Chengdu2 Chongqing2 Guangzhou2
All 21 locations
Target enrolment
to

Lung Adenocarcinoma trials in China

18 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
NCT07481786Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou
2026-03-20
Not yet open
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
NCT07169903Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
587
Shanghai
2025-10-01
Recruiting
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
NCT05925764Lung Adenocarcinoma, Whole Slide Image, IASLC Grading System, Artificial Intelligence
Shanghai Pulmonary Hospital, Shanghai, China
Observational
200
Zunyi, Nanchang, Ningbo
2024-10-15
Recruiting
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
NCT06843629Ovarian Cancer, Lung Adenocarcinoma, Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
100
Wuhan
2024-10-01
Not yet open
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
NCT06619886Solid Tumor, Adult, Lung Adenocarcinoma, Pancreas Cancer, Colorectal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
9
Shanghai
2024-09-24
Recruiting
Segmentectomy for Solid-dominant Lung Cancer
NCT06634966Segmentectomy, Lung Adenocarcinoma
Fudan University
Phase 3
277
Shanghai
2024-07-01
Recruiting
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
NCT05266846ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy
Hunan Province Tumor Hospital
Phase 2
78
Changsha
2024-05-29
Recruiting
Lymph Node Pathologic Grading Strategy
NCT06745830Lung Adenocarcinoma
Fudan University
Observational
2,998
Shanghai
2024-04-10
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
AstraZeneca
Phase 1/2
602
Chengdu, Chongqing, Guangzhou, Jinan, Xi'an, Zhengzhou
2023-06-05
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NCT06056115Lung Adenocarcinoma
Hebei Medical University Fourth Hospital
Not applicable
20
Shijiazhuang
2023-05-01
Recruiting
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
NCT06031246Lung Adenocarcinoma, Lymph Node Metastasis
Fudan University
Phase 3
634
Shanghai
2023-04-01
Recruiting
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
NCT06031181Lung Adenocarcinoma, Frozen Section, Sublobar Resection
Fudan University
Phase 3
390
Shanghai
2023-03-31
Recruiting
Shared Decision Making in Patients With Lung Cancer
NCT05191485Surgery, Lung Adenocarcinoma
Sichuan Cancer Hospital and Research Institute
Observational
190
Chengdu
2023-02-22
Recruiting
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
NCT05717803Segmentectomy, Lung Adenocarcinoma
Fudan University
Phase 3
307
Shanghai
2023-02-15
By invitation
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
NCT06730477Lung Adenocarcinoma, EGFR Activating Mutation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
500
Wuhan
2021-01-01
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60,000
Beijing
2019-11-04
Recruiting
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma โ‰ค 2cm
NCT04937283Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Recruiting
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma โ‰ค 2cm
NCT05838053Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Observational
446
Yangpu
2019-08-20
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/condition/lung-adenocarcinoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies listing the condition Lung Adenocarcinoma.

How many Lung Adenocarcinoma trials are recruiting in China?

15 of the 18 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lung Adenocarcinoma), 18 studies
PhaseStudiesRecruitingShare
Observational7638.9%
Phase 36533.3%
Not applicable2211.1%
Phase 1/2115.6%
Phase 2115.6%
Phase EARLY_PHASE1105.6%

Most active sponsors

Lead sponsors with the most studies (Lung Adenocarcinoma)
Lead sponsorStudiesRecruiting
Fudan University55
Shanghai Pulmonary Hospital, Shanghai, China43
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology21
AstraZeneca11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Hebei Medical University Fourth Hospital11
Hunan Province Tumor Hospital11
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine10
Sichuan Cancer Hospital and Research Institute11
Sun Yat-sen University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.